Search results for "DELETION"

showing 10 items of 383 documents

NAIP-deltaEx10-11: a novel splice variant of the apoptosis inhibitor NAIP differently expressed in drug-sensitive and multidrug-resistant HL60 leukem…

2002

Alterations of neuronal apoptosis inhibitory protein (NAIP), a member of the inhibitory of apoptosis protein (IAP) family of inhibitors of apoptosis, have been previously associated with different neurodegenerative disorders. This study indicated the existence of a novel NAIP splice variant. This isoform, NAIP-deltaEx10-11, was found in tumor cell lines of different origin and in normal adult brain. Analysis of the putative protein predicted that the NAIP variant lacks part of the third BIR domain as well as the COOH-terminal tail of regular NAIP. This might suggest that it is endowed with a reduced antiapoptotic activity. This view is supported by the fact that NAIP-deltaEx10-11 mRNA and p…

Gene isoformCancer ResearchApoptosis InhibitorHL60ApoptosisHL-60 CellsNerve Tissue ProteinsBiologyExonchemistry.chemical_compoundmedicineRNA PrecursorsTumor Cells CulturedHumansProtein IsoformsRNA NeoplasmSequence DeletionGeneticsBrain ChemistryAlternative splicingHematologyExonsmedicine.diseaseDrug Resistance MultipleNeuronal Apoptosis-Inhibitory ProteinNeoplasm ProteinsProtein Structure TertiaryLeukemiaAlternative SplicingOncologychemistryApoptosisDrug Resistance NeoplasmCancer researchNAIPLeukemia research
researchProduct

Neuronal-Type NO Synthase: Transcript Diversity and Expressional Regulation

1998

Of the three established isoforms of NO synthase, the gene for the neuronal-type enzyme (NOS I) is by far the largest and most complicated one. The genomic locus of the human NOS I gene is located on chromosome 12 and distributed over a region greater than 200 kb. The nucleotide sequence corresponding to the major neuronal mRNA transcript is encoded by 29 exons. The full-length open reading frame codes for a protein of 1434 amino acids with a predicted molecular weight of 160.8 kDa. However, both in rodents and in humans, multiple, tissue-specific or developmentally regulated NOS I mRNA transcripts have been reported. They arise from the initiation by different transcriptional units contain…

Gene isoformCancer ResearchTranscription GeneticPolyadenylationPhysiologyClinical BiochemistryNitric Oxide Synthase Type IILocus (genetics)BiologyBiochemistryGene Expression Regulation EnzymologicExonGene expressionTranscriptional regulationAnimalsHumansRNA MessengerPromoter Regions GeneticGeneSequence DeletionMammalsGeneticsChromosomes Human Pair 12Gene Expression Regulation DevelopmentalAlternative SplicingOpen reading frameNitric Oxide SynthaseNitric Oxide
researchProduct

Contribution of insertions and deletions to the variability of hepatitis C virus populations

2007

Little is known about the potential effects of insertions and deletions (indels) on the evolutionary dynamics of hepatitis C virus (HCV). In fact, the consequences of indels on antiviral treatment response are a field of investigation completely unexplored. Here, an extensive sequencing project was undertaken by cloning and sequencing serum samples from 25 patients infected with HCV subtype 1a and 48 patients with subtype 1b. For 23 patients, samples obtained after treatment with alpha interferon plus ribavirin were also available. Two genome fragments containing the hypervariable regions in the envelope 2 glycoprotein and the PKR-BD domain in NS5A were sequenced, yielding almost 16 000 seq…

Genes ViralHepatitis C virusMolecular Sequence DataAlpha interferonHepacivirusViral quasispeciesViral Nonstructural ProteinsBiologymedicine.disease_causeAntiviral AgentsGenomeVirusSpecies SpecificityViral Envelope ProteinsVirologyRibavirinmedicineHumansAmino Acid SequenceNS5AIndelGeneticsInterferon-alphavirus diseasesHepatitis CVirologyHypervariable regionMutagenesis InsertionalSpainDrug Therapy CombinationSequence AlignmentGene DeletionJournal of General Virology
researchProduct

Basic phenotypic analysis of six novel yeast genes reveals two essential genes and one which affects the growth rate

1999

Phenotypic analysis was performed on six mutants of Saccharomyces cerevisiae deleted in one of the following open reading frames (ORFs), located on chromosome II: YBR254c, YBR255w, YBR257w, YBR258c, YBR259w and YBR266c. Disruption of the ORFs was carried out in the diploid strain FY1679 using the kanMX4 marker flanked by short sequences homologous to the target locus. Tetrad analysis following sporulation of the heterozygous disruptants showed that YBR254c and YBR257w are essential genes. YBR257w was later characterized and renamed POP4, its gene product being involved in 5.8S rRNA and tRNA processing (Chu et al., 1997). The tetrad analysis performed for the heterozygous disruptant for YBR2…

Genetic MarkersGeneticsGenes FungalMutantSaccharomyces cerevisiaeTRNA processingBioengineeringLocus (genetics)Saccharomyces cerevisiaeBiologybiology.organism_classificationPolymerase Chain ReactionApplied Microbiology and BiotechnologyBiochemistryComplementationOpen Reading FramesOpen reading framePhenotypeGeneticsChromosomes FungalORFSGeneGene DeletionBiotechnologyYeast
researchProduct

Pleomorphic anaplastic neuroblastoma

2000

Genetic MarkersMaleCancer ResearchPathologymedicine.medical_specialtyGenes mycDiagnostic aidNeuroblastomaFatal OutcomeNeuroblastomamedicineHumansPleomorphic anaplastic neuroblastomaAnaplasiaAnaplasiabusiness.industryPrognosismedicine.diseaseImmunohistochemistryOncologyPleomorphism (cytology)Chromosomes Human Pair 1Abdominal NeoplasmsChild PreschoolPediatrics Perinatology and Child Healthmedicine.symptombusinessAutonomic neuropathyGene DeletionMedical and Pediatric Oncology
researchProduct

The copy number variant involving part of the α7 nicotinic receptor gene contains a polymorphic inversion.

2008

The alpha7 nicotinic acetylcholine receptor gene (CHRNA7) is located at 15q13-q14 in a region that is strongly linked to the P50 sensory gating deficit, an endophenotype of schizophrenia and bipolar disorder. Part of the gene is a copy number variant, due to a duplication of exons 5-10 and 3' sequence in CHRFAM7A, which is present in many but not all humans. Maps of this region show that the two genes are in opposite orientation in the individual mainly represented in the public access human DNA sequence database (Build 36), suggesting that an inversion had occurred since the duplication. We have used fluorescent in situ hybridization to investigate this putative inversion. Analysis of inte…

Genetic MarkersMaleLinkage disequilibriumBipolar DisorderPan troglodytesalpha7 Nicotinic Acetylcholine ReceptorReceptors NicotinicLinkage DisequilibriumExonGene duplicationGeneticsSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.AnimalsHumansCopy-number variationGeneSettore MED/25 - PsichiatriaGenetics (clinical)Sequence DeletionSegmental duplicationChromosomal inversionGeneticsChromosomes Human Pair 15Polymorphism GeneticBase SequencebiologyCHRNA7Chromosome Mappinginversion schizophrenia bipolar disorder 15q13–q14 CHRNA7 segmental duplicationChromosome InversionSchizophreniabiology.proteinFemale
researchProduct

Identification of sequences in the human peptide transporter subunit TAP1 required for transporter associated with antigen processing (TAP) function

2001

The heterodimeric peptide transporter associated with antigen processing (TAP) consisting of the subunits TAP1 and TAP2 mediates the transport of cytosolic peptides into the lumen of the endoplasmic reticulum (ER). In order to accurately define domains required for peptide transporter function, a molecular approach based on the construction of a panel of human TAP1 mutants and their expression in TAP1(-/-) cells was employed. The characteristics and biological activity of the various TAP1 mutants were determined, and compared to that of wild-type TAP1 and TAP1(-/-) control cells. All mutant TAP1 proteins were localized in the ER and were capable of forming complexes with the TAP2 subunit. H…

Genetic VectorsImmunologyAntigen presentationBiological Transport ActiveEpitopes T-LymphocyteTransfectionMajor histocompatibility complexMiceAntigenATP Binding Cassette Transporter Subfamily B Member 3MHC class ITumor Cells CulturedAnimalsHumansLymphocytic choriomeningitis virusImmunology and AllergyAmino Acid SequenceATP Binding Cassette Transporter Subfamily B Member 2Sequence DeletionMice KnockoutAntigen PresentationbiologyAntigen processingHistocompatibility Antigens Class IGeneral MedicineTransporter associated with antigen processingMHC restrictionCytotoxicity Tests ImmunologicMolecular biologyPeptide FragmentsCell biologyMice Inbred C57BLPeptide transportMutagenesis Site-Directedbiology.proteinATP-Binding Cassette TransportersDimerizationT-Lymphocytes CytotoxicInternational Immunology
researchProduct

Homozygous SMN1 exons 1-6 deletion: pitfalls in genetic counseling and general recommendations for spinal muscular atrophy molecular diagnosis.

2012

We report on a rare homozygous intragenic deletion encompassing exons 1-6 of the SMN1 gene in a patient with spinal muscular atrophy (SMA) born into a consanguineous family. This exceptional configuration induced misinterpretation of the molecular defect involved in this patient, who was first reported as having a classic SMN1 exon 7 deletion. This case points out the possible pitfalls in molecular diagnosis of SMA in affected patients and their relatives: exploration of the SMN1 exon 7 (c.840C/T alleles) may be disturbed by several non-pathological or pathological variants around the SMN1 exon 7. In order to accurately describe the molecular defect in an SMA-affected patient, we propose to…

Genetic counselingGenetic CounselingSMN1BiologyMuscular Atrophy SpinalExonGeneticsmedicineHumansAlleleGeneGenetics (clinical)AllelesGeneticsHomozygoteChromosome MappingInfantSpinal muscular atrophyExonsmedicine.diseaseSMA*Survival of Motor Neuron 1 Proteinnervous system diseasesPedigreeHuman genomeFemaleGene DeletionAmerican journal of medical genetics. Part A
researchProduct

A ceRNA approach may unveil unexpected contributors to deletion syndromes, the model of 5q- syndrome.

2015

In genomic deletions, gene haploinsufficiency might directly configure a specific disease phenotype. Nevertheless, in some cases no functional association can be identified between haploinsufficient genes and the deletion-associated phenotype. Transcripts can act as microRNA sponges. The reduction of transcripts from the hemizygous region may increase the availability of specific microRNAs, which in turn may exert in-trans regulation of target genes outside the deleted region, eventually contributing to the phenotype. Here we prospect a competing endogenous RNA (ceRNA) approach for the identification of candidate genes target of epigenetic regulation in deletion syndromes. As a model, we an…

GeneticsCancer ResearchCandidate gene5q- syndromeCompeting endogenous RNAgenomic deletionsSettore BIO/11 - Biologia MolecolareBiologySettore MED/08 - Anatomia PatologicaPhenotypemyelodysplastic syndromeTranscriptomecompeting endogenous RNAsOncologymicroRNAResearch PerspectiveCeRNAcompeting endogenous RNAEpigeneticsgenomic deletion5q- syndrome; CeRNA; competing endogenous RNAs; genomic deletions; myelodysplastic syndromeHaploinsufficiencyGeneOncoscience
researchProduct

Putative Breast Cancer Driver Mutations in TBX3 Cause Impaired Transcriptional Repression

2015

The closely related T-box transcription factors TBX2 and TBX3 are frequently overexpressed in melanoma and various types of human cancers, in particular, breast cancer. The overexpression of TBX2 and TBX3 can have several cellular effects, among them suppression of senescence, promotion of epithelial–mesenchymal transition, and invasive cell motility. In contrast, loss of function of TBX3 and most other human T-box genes causes developmental haploinsufficiency syndromes. Stephens and colleagues (1), by exome sequencing of breast tumor samples, identified five different mutations in TBX3, all affecting the DNA-binding T-domain. One in-frame deletion of a single amino acid, p.N212delN, was ob…

GeneticsCancer Researchp21frameshift mutationin-frame deletionMelanomadriver mutationTBX3Biologylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaselcsh:RC254-282Frameshift mutationbreast cancerBreast cancerOncologymedicinesomatic mutationsHaploinsufficiencyGeneTranscription factorLoss functionExome sequencingOriginal ResearchFrontiers in Oncology
researchProduct